Physician profile
Timothy E Snell
NPI 1093774341
$8,285.33
in general payments reported to CMS, 2019-2025
25 companies · $1,048 in 2025
The $1,048 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2020: $648 · 2021: $1,569 · 2022: $2,452 · 2023: $669 · 2024: $890 · 2025: $1,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,052 · Consulting Fee: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,052.33 |
| Consulting Fee | $555.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,610.87 | 2019-2025 | Eterna, Proclaim |
| Boston Scientific Corporation | $1,992.79 | 2019-2025 | Na, Wavewriter Alpha Prime 16, General - Pain Management |
| Nalu Medical, INC. | $1,226.35 | 2022-2025 | Nalu Neurostimulation System |
| Abbvie INC. | $932.20 | 2021-2025 | Ubrelvy, Qulipta |
| Stimwave Technologies Incorporated | $313.84 | 2019-2022 | |
| Medtronic, INC. | $235.07 | 2022-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Lilly USA, LLC | $173.13 | 2020-2023 | Reyvow, Emgality |
| Medtronic USA, INC. | $154.81 | 2019-2020 | |
| Globus Medical, INC. | $111.79 | 2025 | Senza |
| Curonix LLC | $108.20 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Saluda Medical Americas, INC. | $62.37 | 2024 | Evoke |
| Nevro Corp. | $54.39 | 2019-2021 | |
| Pfizer INC. | $52.55 | 2019-2025 | |
| Flowonix Medical Incorporated | $40.27 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.41 | 2020-2024 | Relistor |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $31.38 | 2024-2025 | |
| Spr Therapeutics, INC | $28.62 | 2022-2024 | Sprint Pns System |
| Biotronik Nro, INC. | $24.60 | 2025 | Prospera |
| Allergan, INC. | $17.04 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.62 | 2019 | |
| Fidia Pharma USA INC. | $15.68 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.78 | 2019 | |
| Indivior INC. | $13.19 | 2019 | |
| Stryker Corporation | $12.60 | 2019 | |
| Grt US Holding, INC. | $10.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Snell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.